Jörg Schüttrumpf Selected Research

Jörg Schüttrumpf Research Topics

Disease

6	Hemophilia A (Haemophilia) 01/2021 - 01/2012
4	Pneumonia (Pneumonitis) 11/2023 - 01/2018
4	Neoplasms (Cancer) 01/2023 - 06/2012
3	Inflammation (Inflammations) 11/2023 - 01/2021
2	Hepatitis B 01/2023 - 02/2013
2	Pneumococcal Pneumonia 07/2022 - 12/2020
2	Infections 07/2021 - 11/2016
2	Hepatitis C 11/2016 - 02/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 04/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Tics (Tic) 01/2023
1	COVID-19 01/2021
1	Superinfection 12/2020
1	Thrombosis (Thrombus) 12/2020
1	Breast Neoplasms (Breast Cancer) 04/2018
1	Multiple Myeloma 04/2018
1	Triple Negative Breast Neoplasms 04/2018
1	Rheumatoid Arthritis 12/2016
1	End Stage Liver Disease 11/2016
1	Wounds and Injuries (Trauma) 06/2012
1	Transfusion Reaction 06/2012

Drug/Important Bio-Agent (IBA)

7	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 11/2016
5	trimodulinIBA 11/2023 - 01/2018
4	Immunoglobulin A (IgA)IBA 11/2023 - 01/2018
4	Factor VIII (Coagulation Factor VIII)IBA 01/2021 - 01/2012
3	Immunoglobulin G (IgG)IBA 11/2023 - 01/2018
2	Immunoglobulin M (IgM)IBA 11/2023 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2021
2	Streptococcus pneumoniae plY proteinIBA 07/2022 - 12/2020
2	AntibodiesIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 12/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 01/2012
1	C-Reactive ProteinIBA 11/2023
1	ProcalcitoninIBA 11/2023
1	hepatitis B hyperimmune globulinIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023
1	CateninsIBA 01/2023
1	LipopolysaccharidesIBA 12/2021
1	AnaphylatoxinsIBA 07/2021
1	Complement System Proteins (Complement)IBA 07/2021
1	CytokinesIBA 01/2021
1	Fc Receptors (Fc Receptor)IBA 01/2021
1	CalciumIBA 12/2020
1	von Willebrand FactorIBA 11/2019
1	Immunoconjugates (Immunoconjugate)IBA 04/2018
1	indatuximab ravtansineIBA 04/2018
1	Maytansine (Maitansine)IBA 01/2018
1	tregalizumabIBA 12/2016
1	ThioredoxinsIBA 12/2016
1	Antiviral Agents (Antivirals)IBA 11/2016
1	Viral Envelope ProteinsIBA 11/2016
1	Investigational DrugsIBA 11/2016
1	Hepatitis C AntibodiesIBA 11/2016
1	human hepatitis C immune globulinIBA 11/2016
1	N 30IBA 02/2013
1	Blood Coagulation Factors (Coagulation Factor)IBA 02/2013
1	N-acetyltalosaminuronic acid (NAT)IBA 06/2012
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2012
1	Betaine (C.B.B.)FDA Link 01/2012

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2012
2	Liver Transplantation 01/2023 - 11/2016
1	Immunotherapy 01/2023
1	Immunomodulation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Transplantation 04/2014
1	Organ Transplantation 06/2012
1	Drug Therapy (Chemotherapy) 06/2012